{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:46:21Z","timestamp":1790333181972,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2201,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/modpathol.2016.163","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T07:42:13Z","timestamp":1474616533000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cytologic anaplasia is a prognostic factor in osteosarcoma biopsies, but mitotic rate or extent of spontaneous tumor necrosis are not: a critique of the College of American Pathologists Bone Biopsy template"],"prefix":"10.1016","volume":"30","author":[{"given":"Justin MM","family":"Cates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2016.163_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.5858\/134.4.e1","article-title":"Protocol for the examination of specimens from patients with tumors of bone","volume":"134","author":"Rubin","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2016.163_bib2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G","article-title":"Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience","volume":"69","author":"Glasser","year":"1992","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2016.163_bib3","first-page":"221","article-title":"Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor)","volume":"56","author":"Juergens","year":"1981","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1038\/modpathol.2016.163_bib4","series-title":"WHO Classification of Tumours of Soft Tissue and Bone","first-page":"282","author":"Rosenberg","year":"2013"},{"key":"10.1038\/modpathol.2016.163_bib5","series-title":"WHO Classification of Tumours of Soft Tissue and Bone","first-page":"289","author":"Oliveira","year":"2013"},{"key":"10.1038\/modpathol.2016.163_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/01.blo.0000093891.12372.0f","article-title":"A system for the surgical staging of musculoskeletal sarcoma. 1980","volume":"415","author":"Enneking","year":"2003","journal-title":"Clin Orthop Relat Res"},{"key":"10.1038\/modpathol.2016.163_bib7","series-title":"Bone Tumors: Clinical, Radiologic, and Pathologic Correlations","author":"Mirra","year":"1989"},{"key":"10.1038\/modpathol.2016.163_bib8","series-title":"Dorfman and Czerniak's Bone Tumors","author":"Czerniak","year":"2016"},{"key":"10.1038\/modpathol.2016.163_bib9","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.1998.16.2.658","article-title":"Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin","volume":"16","author":"Bacci","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2016.163_bib10","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/cncr.11456","article-title":"Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity: histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor","volume":"97","author":"Bacci","year":"2003","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2016.163_bib11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0959-8049(02)00037-0","article-title":"Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup","volume":"38","author":"Hauben","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2016.163_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01614770","article-title":"Prognostic significance of spontaneous tumour necrosis in osteosarcoma","volume":"423","author":"Bjornsson","year":"1993","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1038\/modpathol.2016.163_bib13","doi-asserted-by":"crossref","unstructured":"Springfield DS, Schakel ME Jr, Spanier SS . Spontaneous necrosis in osteosarcoma. Clin Orthop Relat Res 1991; 233\u2013237.","DOI":"10.1097\/00003086-199102000-00029"},{"key":"10.1038\/modpathol.2016.163_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00776-014-0665-5","article-title":"Spontaneous necrosis and additional tumor necrosis induced by preoperative chemotherapy for osteosarcoma: a case-control study","volume":"20","author":"Song","year":"2015","journal-title":"J Orthop Sci"},{"key":"10.1038\/modpathol.2016.163_bib15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12885-015-1397-4","article-title":"Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy","volume":"15","author":"Robl","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1038\/modpathol.2016.163_bib16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/1097-0142(19950201)75:3<806::AID-CNCR2820750310>3.0.CO;2-S","article-title":"Clinical relevance of Ki-67 expression in bone tumors","volume":"75","author":"Scotlandi","year":"1995","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2016.163_bib17","first-page":"210","article-title":"Ki-67: a proliferative marker that may predict pulmonary metastases and mortality of primary osteosarcoma","volume":"25","author":"Hernandez-Rodriguez","year":"2001","journal-title":"Cancer Detect Prev"},{"key":"10.1038\/modpathol.2016.163_bib18","doi-asserted-by":"crossref","first-page":"874075","DOI":"10.1155\/2008\/874075","article-title":"Immunohistochemical estimates of angiogenesis, proliferative activity, p53 expression, and multiple drug resistance have no prognostic impact in osteosarcoma: a comparative clinicopathological investigation","volume":"2008","author":"Sorensen","year":"2008","journal-title":"Sarcoma"},{"key":"10.1038\/modpathol.2016.163_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1155\/S1357714X00000086","article-title":"Proliferative activity (ki-67 expression) and outcome in high grade osteosarcoma: a study of 27 cases","volume":"4","author":"Jong","year":"2000","journal-title":"Sarcoma"},{"key":"10.1038\/modpathol.2016.163_bib20","first-page":"1007","article-title":"Prognostic significance of cyclin expression in human osteosarcoma","volume":"12","author":"Molendini","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1038\/modpathol.2016.163_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/bjc.1952.5","article-title":"The grading of osteogenic sarcoma","volume":"6","author":"Price","year":"1952","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2016.163_bib22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/17453677808993240","article-title":"Osteosarcoma: a multifactorial clinical and histopathological study with special regard to therapy and survival","volume":"49","author":"Larsson","year":"1978","journal-title":"Acta Orthop Scand"},{"key":"10.1038\/modpathol.2016.163_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00433573","article-title":"Osteosarcoma: histological evaluation and grading","volume":"94","author":"Meister","year":"1979","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1038\/modpathol.2016.163_bib24","first-page":"5","article-title":"Osteosarcoma: a review of 345 cases","volume":"1","author":"Campanacci","year":"1975","journal-title":"Ital J Orthop Traumatol"},{"key":"10.1038\/modpathol.2016.163_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajcp\/53.1.15","article-title":"The unreliability of prognostic criteria in osteosarcoma","volume":"53","author":"Gavanis","year":"1970","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2016.163_bib26","series-title":"SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics","first-page":"81","author":"Lewis","year":"2007"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016163","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222019378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222019378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:54:58Z","timestamp":1760230498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222019378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0893395222019378"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2016.163","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytologic anaplasia is a prognostic factor in osteosarcoma biopsies, but mitotic rate or extent of spontaneous tumor necrosis are not: a critique of the College of American Pathologists Bone Biopsy template","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2016.163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}